Abstract
We read with great interest the article by Chan et al. (1) demonstrating that fibroblast growth factor 23 (FGF23) concentration is a novel predictor of mortality in African Americans with type 2 diabetes. FGF23 is the main hormone mediating serum phosphorus concentration through inhibiting tubular reabsorption of phosphorus from the urine (2). Meanwhile, serum phosphorus is the main stimulus for FGF23 secretion. In progressive chronic kidney disease …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
